Kenvue /KVUE

$18.82

-1%
-
1D1W1MYTD1YMAX

About Kenvue

Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment product categories include cough, cold and allergy; pain care; and other self-care (digestive health, smoking cessation and other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health and wound care). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. It has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. Its network includes 114 distribution centers and 38 customer service centers across all its regions.

Ticker

KVUE

Sector

Consumer Non-Cyclicals

Trading on

NYSE

Industry

Personal & Household Prods.

CEO

Thibaut Mongon

Employees

22,200

Headquarters

Skillman, United States

Kenvue Metrics

BasicAdvanced
$36.38B
Market cap
21.63
P/E ratio
$0.88
EPS
-
Beta
$0.40
Dividend rate
4.21%
Dividend yield

What the Analysts think about Kenvue

Analyst Ratings

Majority rating from 14 analysts.
Buy

Price Targets

Average projection from 11 analysts.
18.81% upside
High $25.00
Low $20.00
$18.82
Current price
$22.36
Average price target

Kenvue Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
8.91% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$3.67B
-6.36%
Net income
$327M
-25.34%
Profit margin
8.91%
-20.3%

Kenvue Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.66%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.37
$0.32
$0.31
$0.31
-
Expected
$0.32
$0.30
$0.31
$0.28
$0.26
Surprise
15.63%
5.96%
-1%
10.66%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Kenvue  stock

Buy or sell Kenvue stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing